Dr. Xavier Maréchal is a biochemist specializing in enzymology and RT‑qPCR. He earned his PhD from the University Pierre et Marie Curie in Paris in 2011. During his doctoral training and subsequent postdoctoral positions at the Institut Pasteur de Lille and the CEA (Commissariat à l’Énergie Atomique et aux Énergies Alternatives), he focused on drug discovery, developing high‑throughput screening (HTS) assays, running HTS campaigns, and evaluating compounds throughout the hit‑to‑lead process in close collaboration with medicinal chemists. Xavier joined Evotec in 2018, where he further specialized in the design and optimization of RT‑qPCR‑based HTS approaches for the identification of gene expression and mRNA splicing modulators. He now serves as a Team Leader within the High Throughput Screening and Biology department.